-
Is the Pharmaceutical Innovation Model Broken? And can Open Innovation Mend it?
October 6, 2013 Editor 0
This IM Channel One Ask the Expert Q&A hosted by NineSigma shares hands-on experiences on how open Innovation can be applied to mitigate operator bias in the pharma industry. By formulating business cases that address global healthcare needs, the pharmaceutical industry can open new avenues of innovation that are built on existing solid assets, developing accessory devices and services, creating user communities (medical and/or patient) and strategies to defend against the generic erosion of revenue.
Go to SourceRelated Posts
Economic rewards of better land management: Estimated 2.3 billion tons of crops worth $1.4 trillion
SRF – a class of its own
Exit an Unprofitable Line of Business
Give Thanks, Give a Solar Powered Digital Library!
Ramesh Sawant: Story of an Entrepreneur’s Journey without the Map1- Innovation prize set to reward African inventors
A Global Online Network Lets Health Professionals Share Expertise T-shirts, technology and trade: Planet Money host says experimentation, not theory, key to cutting poverty
